Inventor · disambiguated record
Pooran Chand
Also filed as: CHAND POORAN
34 granted patents·24 pending applications·866 citations·filing 1995–2024
98Inventor score
Files withBIOCRYST PHARM INC26BABU YARLAGADDA S9EIDOS THERAPEUTICS INC5ADVANCED CANCER THERAPEUTICS LLC3CLEM BRIAN2
Top patents by PatentIndex Score
58 records- 0198US7560434B2AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2005·Granted Jul 14, 2009·92 cites·29 claims
- 0297US7994139B2Antiviral therapeutic agentsBIOCRYST PHARM INC·Filed 2009·Granted Aug 9, 2011·81 cites·24 claims
- 0397US7429571B2Therapeutic furopyrimidines and thienopyrimidinesBIOCRYST PHARM INC·Filed 2006·Granted Sep 30, 2008·84 cites·16 claims
- 0496US8242085B2Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancerBABU YARLAGADDA S·Filed 2008·Granted Aug 14, 2012·81 cites·46 claims
- 0596US7514410B2Hepatitis C therapiesBIOCRYST PHARM INC·Filed 2006·Granted Apr 7, 2009·80 cites·42 claims
- 0696US7388002B2Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2005·Granted Jun 17, 2008·39 cites·16 claims
- 0795US8440813B2Antiviral nucleoside analogsBABU YARLAGADDA S·Filed 2008·Granted May 14, 2013·42 cites·1 claims
- 0895US8133870B2Therapeutic furopyrimidines and thienopyrimidinesBABU YARLAGADDA S·Filed 2005·Granted Mar 13, 2012·32 cites·24 claims
- 0995US6699994B1Biaryl compounds as serine protease inhibitorsBIOCRYST PHARM INC·Filed 2002·Granted Mar 2, 2004·87 cites·21 claims
- 1093US11078162B2Processes for preparing AG-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2019·Granted Aug 3, 2021·5 cites·54 claims
- 1192US8163703B2Hepatitis C therapiesBABU YARLAGADDA S·Filed 2009·Granted Apr 24, 2012·27 cites·31 claims
- 1290US11919865B2Processes for preparing AG-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2021·Granted Mar 5, 2024·1 cites·16 claims
- 1390US2025313534A1Processes for preparing ag-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1489US10513497B2Process for preparing AG-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·6 cites·10 claims
- 1589US6936719B2Biaryl compounds as serine protease inhibitorsBIOCRYST PHARM INC·Filed 2003·Granted Aug 30, 2005·37 cites·18 claims
- 1689US6503745B1Cyclopentane and cyclopentene compounds and use for detecting influenza virusBIOCRYST PHARM INC·Filed 1999·Granted Jan 7, 2003·42 cites·39 claims
- 1788US2024239751A1Processes for preparing ag-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1887US5602277ASubstituted benzene derivatives useful as neuraminidase inhibitorsBIOCRYST PHARM INC·Filed 1995·Granted Feb 11, 1997·33 cites·25 claims
- 1985US8557823B2Family of PFKFB3 inhibitors with anti-neoplastic activitiesTAPOLSKY GILLES·Filed 2011·Granted Oct 15, 2013·18 cites·3 claims
- 2085US6518299B1Substituted pyrrolidine compounds useful as neuraminidase inhibitorsBIOCRYST PHARM INC·Filed 2000·Granted Feb 11, 2003·13 cites·1 claims
- 2183US6562861B1Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitorsBIOCRYST PHARM INC·Filed 1998·Granted May 13, 2003·31 cites·41 claims
- 2281US9770427B2Antiviral treatmentsBIOCRYST PHARM INC·Filed 2014·Granted Sep 26, 2017·3 cites·18 claims
- 2377US12121503B2Antiviral treatmentsBIOCRYST PHARM INC·Filed 2021·Granted Oct 22, 2024·0 cites·13 claims
- 2477US7230119B2Process for the preparation of substituted pyrrolidine derivatives and intermediatesBIOCRYST PHARM INC·Filed 2005·Granted Jun 12, 2007·2 cites·10 claims
- 2577US6762316B1Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediatesBIOCRYST PHARM INC·Filed 2000·Granted Jul 13, 2004·9 cites·1 claims
- 2676US11464755B2Antiviral treatmentsBIOCRYST PHARM INC·Filed 2019·Granted Oct 11, 2022·0 cites·23 claims
- 2775US8778997B2Antiviral treatmentsBABU YARLAGADDA SUDHAKARA·Filed 2011·Granted Jul 15, 2014·3 cites·8 claims
- 2870US9403769B2Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeuticsCHAND POORAN·Filed 2011·Granted Aug 2, 2016·2 cites·12 claims
- 2964US2024287089A1Preparation and Uses of 7-AzaindenoisoquinolinesPURDUE RESEARCH FOUNDATION·Filed 2024·Application pending·0 cites
- 3063US10010542B2PFKFB3 inhibit and methods of use as an anti-cancer therapeuticADVANCED CANCER THERAPEUTICS LLC·Filed 2017·Granted Jul 3, 2018·0 cites·11 claims
- 3161US7045535B2Compounds useful for inhibiting paramyxovirus neuraminidaseBIOCRYST PHARM INC·Filed 2002·Granted May 16, 2006·2 cites·14 claims
- 3260US2025074917A1Preparation and Uses of 7-AzaindenoisoquinolinesPURDUE RESEARCH FOUNDATION·Filed 2023·Application pending·0 cites
- 3360US2007203241A1Antiviral treatmentsBABU YARLAGADDA S·Filed 2007·Application pending·0 cites
- 3460US2018009764A1Method for treating macrophage migration inhibitory factor (mif)-implicated diseases and conditions with iodo pyrimidine derivativesUNIV LOUISVILLE RES FOUND INC·Filed 2017·Application pending·0 cites
- 3558US10391075B2Antiviral treatmentsBIOCRYST PHARMACEUTICALS·Filed 2017·Granted Aug 27, 2019·0 cites·21 claims
- 3658US6410594B1Substituted cyclopentane compounds useful as neuraminidase inhibitorsBIOCRYST PHARM INC·Filed 1997·Granted Jun 25, 2002·14 cites·31 claims
- 3758US2004014722A1Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2003·Application pending·0 cites
- 3857US9162987B2Iodo pyrimidine derivatives useful for the treatment of macrophage migration inhibitory factor (MIF)-implicated diseases and conditionsMITCHELL ROBERT A·Filed 2010·Granted Oct 20, 2015·0 cites·5 claims
- 3956US2005033051A1Nucleosides preparation thereof and use as inhibitors of rna viral polymerasesFiled 2002·Application pending·0 cites
- 4055US9649305B2PFKFB3 inhibitor and methods of use as an anti-cancer therapeuticADVANCED CANCER THERAPEUTICS LLC·Filed 2013·Granted May 16, 2017·0 cites·17 claims
- 4155US2015368207A1Method for treating macrophage migration inhibitory factor (mif)-implicated diseases and conditions with iodo pyrimidine derivativesUNIV LOUISVILLE RES FOUND·Filed 2015·Application pending·0 cites
- 4255US2009247750A1Process for preparing nucleoside analogsBIOCRYST PHARM INC·Filed 2009·Application pending·0 cites
- 4355US2011144321A1Synthetic intermediates and processesBIOCRYST PHARM INC·Filed 2009·Application pending·0 cites
- 4454US9381172B2Small molecule choline kinase inhibitors, screening assays, and methods for treatment of neoplastic disordersCLEM BRIAN·Filed 2012·Granted Jul 5, 2016·0 cites·15 claims
- 4554US2004242599A1Cyclopentene nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2004·Application pending·0 cites
- 4653US2011165183A1Piperidine derivatives as jak3 inhibitorsBIOCRYST PHARM INC·Filed 2009·Application pending·0 cites
- 4753US2012213735A1Therapeutic furopyrimidines and thienopyrimidinesBABU YARLAGADDA S·Filed 2012·Application pending·0 cites
- 4852US2013078218A1Hepatitis c therapiesBABU YARLAGADDA S·Filed 2012·Application pending·0 cites
- 4951US2007244193A1Intramuscular antiviral treatmentsBABU YARLAGADDA S·Filed 2006·Application pending·0 cites
- 5050US2004229839A1Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →